Global Medical REIT Inc. (GMRE)
NYSE: GMRE · IEX Real-Time Price · USD
8.12
+0.06 (0.74%)
At close: Apr 18, 2024, 4:00 PM
8.18
+0.06 (0.74%)
After-hours: Apr 18, 2024, 7:44 PM EDT
Global Medical REIT Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Global Medical REIT stock has a target of 11, which predicts an increase of 35.47% from the current stock price of 8.12.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 8, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for GMRE is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 | May '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 2 | 2 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +35.47% | May 8, 2023 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +47.78% | Mar 6, 2023 |
| Baird | Baird | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 10, 2022 |
| BMO Capital | BMO Capital | Buy → Hold Downgrades $13 → $9 | Buy → Hold | Downgrades | $13 → $9 | +10.84% | Oct 6, 2022 |
| Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 13, 2022 |
Financial Forecast
Revenue This Year
138.86M
from 141.05M
Decreased by -1.55%
Revenue Next Year
144.93M
from 138.86M
Increased by 4.37%
EPS This Year
0.01
from 0.23
Decreased by -94.09%
EPS Next Year
0.03
from 0.01
Increased by 125.06%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 149.3M | 157.3M | 164.9M |
| Avg | 138.9M | 144.9M | 149.3M |
| Low | 128.8M | 132.0M | 134.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 5.9% | 13.3% | 13.8% |
| Avg | -1.6% | 4.4% | 3.0% |
| Low | -8.7% | -5.0% | -7.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.07 | 0.05 | 0.04 |
| Avg | 0.01 | 0.03 | 0.04 |
| Low | -0.02 | 0.01 | 0.04 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -68.0% | 286.1% | 37.3% |
| Avg | -94.1% | 125.1% | 33.3% |
| Low | - | -27.9% | 28.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.